Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection.
Colvin RA, Tanwandee T, Piratvisuth T, Thongsawat S, Hui AJ, Zhang H, Ren H, Chen PJ, Chuang WL, Sobhonslidsuk A, Li R, Qi Y, Praestgaard J, Han Y, Xu J, Stein DS; ABF656A2206 Study Group. Colvin RA, et al. Among authors: stein ds. J Gastroenterol Hepatol. 2015 Jan;30(1):184-91. doi: 10.1111/jgh.12671. J Gastroenterol Hepatol. 2015. PMID: 24995515 Clinical Trial.
Single-dose pharmacokinetics, safety, and tolerability of albinterferon alfa-2b in subjects with end-stage renal disease on hemodialysis compared to those in matched healthy volunteers.
Serra DB, Sun H, Karwowska S, Praestgaard J, Halabi A, Stein DS. Serra DB, et al. Among authors: stein ds. Antimicrob Agents Chemother. 2011 Feb;55(2):473-7. doi: 10.1128/AAC.00626-10. Epub 2010 Nov 22. Antimicrob Agents Chemother. 2011. PMID: 21098255 Free PMC article. Clinical Trial.
Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects.
Sun H, Ting L, Machineni S, Praestgaard J, Kuemmell A, Stein DS, Sunkara G, Kovacs SJ, Villano S, Tanaka SK. Sun H, et al. Among authors: stein ds. Antimicrob Agents Chemother. 2016 Nov 21;60(12):7431-7435. doi: 10.1128/AAC.01393-16. Print 2016 Dec. Antimicrob Agents Chemother. 2016. PMID: 27736760 Free PMC article. Clinical Trial.
Correction for Kovacs et al., "An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline".
Kovacs SJ, Ting L, Praestgaard J, Sunkara G, Sun H, Stein DS, Tanaka SK, Villano S. Kovacs SJ, et al. Among authors: stein ds. Antimicrob Agents Chemother. 2020 Dec 16;65(1):e02426-20. doi: 10.1128/AAC.02426-20. Print 2020 Dec 16. Antimicrob Agents Chemother. 2020. PMID: 33328319 Free PMC article. No abstract available.
Population pharmacokinetics and exposure-response of albinterferon alfa-2b.
Riggs MM, Bergsma TT, Rogers JA, Gastonguay MR, Subramanian GM, Chen C, Devalaraja M, Corey AE, Sun H, Yu J, Stein DS. Riggs MM, et al. Among authors: stein ds. J Clin Pharmacol. 2012 Apr;52(4):475-86. doi: 10.1177/0091270011399576. Epub 2011 May 6. J Clin Pharmacol. 2012. PMID: 21551316 Clinical Trial.
Bioavailability of Lumefantrine Is Significantly Enhanced with a Novel Formulation Approach, an Outcome from a Randomized, Open-Label Pharmacokinetic Study in Healthy Volunteers.
Jain JP, Leong FJ, Chen L, Kalluri S, Koradia V, Stein DS, Wolf MC, Sunkara G, Kota J. Jain JP, et al. Among authors: stein ds. Antimicrob Agents Chemother. 2017 Aug 24;61(9):e00868-17. doi: 10.1128/AAC.00868-17. Print 2017 Sep. Antimicrob Agents Chemother. 2017. PMID: 28630183 Free PMC article. Clinical Trial.
144 results